UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

The SOFA score-development, utility and challenges of accurate assessment in clinical trials

Critical care (London, England), 2019-11, Vol.23 (1), p.374-374, Article 374

2019

Volltextzugriff (PDF)

The challenge of ventilator-associated pneumonia diagnosis in COVID-19 patients

Critical care (London, England), 2020-06, Vol.24 (1), p.289-289, Article 289

2020

Volltextzugriff (PDF)

Aerosol delivery during invasive mechanical ventilation: a systematic review

Critical care (London, England), 2017-10, Vol.21 (1), p.264-264, Article 264

2017

Volltextzugriff (PDF)

The INHALE trial: multiple reasons for a negative result

The Lancet infectious diseases, 2020-07, Vol.20 (7), p.778-779

2020

Volltextzugriff (PDF)

Association between in-ICU red blood cells transfusion and 1-year mortality in ICU survivors

Critical care (London, England), 2022-10, Vol.26 (1), p.1-307, Article 307

2022

Volltextzugriff (PDF)

Aerosol Delivery with Two Nebulizers Through High-Flow Nasal Cannula: A Randomized Cross-Over Single-Photon Emission Computed Tomography-Computed Tomography Study

Journal of aerosol medicine and pulmonary drug delivery, 2017-10, Vol.30 (5), p.349

2017

Volltextzugriff (PDF)

Changes in cardiac arrest patients’ temperature management after the 2013 “TTM” trial: results from an international survey

Annals of intensive care, 2016-01, Vol.6 (1), p.4-4, Article 4

2016

Volltextzugriff (PDF)

COVID-19: an ‘extraterrestrial’ disease?

International journal of infectious diseases, 2021-09, Vol.110, p.155-159

2021

Volltextzugriff (PDF)

Guidelines for management of intra-abdominal infections

Anaesthesia critical care & pain medicine, 2015-04, Vol.34 (2), p.117-130

2015

Volltextzugriff (PDF)

Use of pragmatic and explanatory trial designs in acute care research: lessons from COVID-19

The lancet respiratory medicine, 2022-07, Vol.10 (7), p.700-714

2022

Volltextzugriff (PDF)

Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes

Critical care (London, England), 2014-01, Vol.18 (1), p.R17-R17

2014

Volltextzugriff (PDF)

Epidural analgesia in critically ill patients with acute pancreatitis: the multicentre randomised controlled EPIPAN study protocol

BMJ open, 2017-05, Vol.7 (5), p.e015280-e015280

2017

Volltextzugriff (PDF)

Evaluation of the efficacy and safety of TREM-1 inhibition with nangibotide in patients with COVID-19 receiving respiratory support: the ESSENTIAL randomised, double-blind trial

EClinicalMedicine, 2023-06, Vol.60, p.102013-102013, Article 102013

2023

Volltextzugriff (PDF)

Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure

Journal of intensive care, 2016-03, Vol.4 (24), p.24-24, Article 24

2016

Volltextzugriff (PDF)

Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injury

Intensive care medicine, 2018-05, Vol.44 (5), p.598-605

2018

Volltextzugriff (PDF)

Safety and tolerability of a single administration of AR-301, a human monoclonal antibody, in ICU patients with severe pneumonia caused by Staphylococcus aureus: first-in-human trial

Intensive care medicine, 2018-11, Vol.44 (11), p.1787-1796

2018

Volltextzugriff (PDF)

Opportunities for improved clinical trial designs in acute respiratory distress syndrome

The lancet respiratory medicine, 2022-09, Vol.10 (9), p.916-924

2022

Volltextzugriff (PDF)

The IASIS, INHALE and VAPORISE trials. Reasons for a triple failure: Study design, aminoglycosides dosing and technique of nebulisation

Anaesthesia critical care & pain medicine, 2020-04, Vol.39 (2), p.179-183

2020

Volltextzugriff (PDF)

Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial

The lancet respiratory medicine, 2023-10, Vol.11 (10), p.894-904

2023

Volltextzugriff (PDF)

Pharmacokinetics of a loading dose of amikacin in septic patients undergoing continuous renal replacement therapy

International journal of antimicrobial agents, 2011-06, Vol.37 (6), p.531-535

2011

Volltextzugriff (PDF)

The Effect of Renal Replacement Therapy and Antibiotic Dose on Antibiotic Concentrations in Critically Ill Patients: Data From the Multinational Sampling Antibiotics in Renal Replacement Therapy Study

Clinical infectious diseases, 2021-04, Vol.72 (8), p.1369-1378

2021

Volltextzugriff (PDF)

Connection Between Cardiac Vascular Permeability, Myocardial Edema, and Inflammation During Sepsis: Role of the α1AMP-Activated Protein Kinase Isoform

Critical care medicine, 2013-12, Vol.41 (12), p.e411-e422

2013

Volltextzugriff (PDF)

Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial

The Lancet infectious diseases, 2021-09, Vol.21 (9), p.1313-1323

2021

Volltextzugriff (PDF)

Thoracic epidural analgesia in intensive care unit patients with acute pancreatitis: the EPIPAN multicenter randomized controlled trial

Critical care (London, England), 2023-05, Vol.27 (1), p.213-213, Article 213

2023

Volltextzugriff (PDF)

Safety and tolerability of a single administration of AR-301, a human monoclonal antibody, in ICU patients with severe pneumonia caused by Staphylococcus aureus: first-in-human trial

Intensive care medicine, 2018-10, Vol.44 (11), p.1787-1796

2018

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

PublikationsformWebseiten

ThemaBiomarkers

ThemaLife Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The SOFA score-development, utility and challenges of accurate assessment in clinical trials

The challenge of ventilator-associated pneumonia diagnosis in COVID-19 patients

Aerosol delivery during invasive mechanical ventilation: a systematic review

The INHALE trial: multiple reasons for a negative result

Association between in-ICU red blood cells transfusion and 1-year mortality in ICU survivors

Aerosol Delivery with Two Nebulizers Through High-Flow Nasal Cannula: A Randomized Cross-Over Single-Photon Emission Computed Tomography-Computed Tomography Study

Changes in cardiac arrest patients’ temperature management after the 2013 “TTM” trial: results from an international survey

COVID-19: an ‘extraterrestrial’ disease?

Guidelines for management of intra-abdominal infections

Use of pragmatic and explanatory trial designs in acute care research: lessons from COVID-19

Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes

Epidural analgesia in critically ill patients with acute pancreatitis: the multicentre randomised controlled EPIPAN study protocol

Evaluation of the efficacy and safety of TREM-1 inhibition with nangibotide in patients with COVID-19 receiving respiratory support: the ESSENTIAL randomised, double-blind trial

Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure

Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injury

Safety and tolerability of a single administration of AR-301, a human monoclonal antibody, in ICU patients with severe pneumonia caused by Staphylococcus aureus: first-in-human trial

Opportunities for improved clinical trial designs in acute respiratory distress syndrome

The IASIS, INHALE and VAPORISE trials. Reasons for a triple failure: Study design, aminoglycosides dosing and technique of nebulisation

Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial

Pharmacokinetics of a loading dose of amikacin in septic patients undergoing continuous renal replacement therapy

The Effect of Renal Replacement Therapy and Antibiotic Dose on Antibiotic Concentrations in Critically Ill Patients: Data From the Multinational Sampling Antibiotics in Renal Replacement Therapy Study

Connection Between Cardiac Vascular Permeability, Myocardial Edema, and Inflammation During Sepsis: Role of the α1AMP-Activated Protein Kinase Isoform

Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial

Thoracic epidural analgesia in intensive care unit patients with acute pancreatitis: the EPIPAN multicenter randomized controlled trial

Safety and tolerability of a single administration of AR-301, a human monoclonal antibody, in ICU patients with severe pneumonia caused by Staphylococcus aureus: first-in-human trial

Aktive Filter

Suchergebnisse filtern